This trial is investigating the role of glycosphingolipids (GSLs) in the development of type II diabetes and cardiovascular disease. They will test the hypotheses that exercise and weight loss interventions will reduce the levels of GSLs in obese diabetic patients and alleviate vascular risk.
2 Primary · 2 Secondary · Reporting Duration: 4 years
60 Total Participants · 2 Treatment Groups
Primary Treatment: Exercise training · No Placebo Group · N/A
Age 18 - 50 · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: